Anlon Healthcare Ltd
Anlon Healthcare Ltd Live Price Chart
Performance
| Previous Close | ₹ 25.11 |
| High | ₹ 26.36 |
| Volume | 4158106 |
| 52W Range | ₹ - ₹ |
| Open | ₹ 26.36 |
| Low | ₹ 25.26 |
| Market Cap | ₹ 1502.59 Cr |
Anlon Healthcare Ltd Technicals
| 20 Day | ₹ 26.275 |
| 50 Day | ₹ 23.953 |
| 100 Day | ₹ 20.731 |
| 200 Day | ₹ 17.763 |
| 20 Day | ₹ 27.844 |
| 50 Day | ₹ 23.118 |
| 100 Day | ₹ 19.168 |
| 200 Day | ₹ 15.990 |
Anlon Healthcare Ltd Fundamentals
| ROCE | 16.696 |
| P/E Ratio | 45.820 |
| P/B Ratio | 6.390 |
| Industry P/E | 6.390 |
| Debt to Equity | 49.856 |
| ROE | 12.488 |
| EPS | 0.550 |
| Dividend Yield | 0.000 |
| Book Value | 3.947 |
| Face Value | 2.000 |
Anlon Healthcare Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 176.7526 | 120.4551 | 66.6919 | 113.1199 | 57.5364 |
| Total Expenses | 136.0769 | 93.5669 | 56.9408 | 106.1267 | 57.6441 |
| Profit After Tax | 27.8082 | 20.518 | 9.6571 | 5.82 | -0.1077 |
Anlon Healthcare Ltd Shareholding Pattern
| Promoter Holdings | 52.680 % |
| FIIs | 0.998 % |
| DIIs | 0.056 % |
| MutualFund | 0.002 % |
| Retail | 29.240 % |
| Others - | 17.024 % |
About Anlon Healthcare Ltd
Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 with the RoC. The Company changed the name to 'Anlon Healthcare Private Limited' dated May 27, 2015 issued by the RoC and further beame a Public Company named 'Anlon Healthcare Limited' dated September 2, 2024. ANLON an ideal API partner is research-driven company engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Bulk Drugs and advanced pharmaceutical intermediates. It specialize in manufacturing of high-purity pharmaceutical intermediates used as key starting materials for APIs and finished dosage formulations. It is among the few Indian manufacturers of products such as Loxoprofen Sodium Dihydrate, Ketoprofen, and Dexketoprofen Trometamol, which are widely used in pain management and anti-inflammatory therapies which comply with the regulatory requirements of leading health authorities such as FDA, PMDA, KFDA, cGMP, WHO-GMP. In addition to manufacturing of Pharma Intermediate and APIs in accordance with various domestic and international standards, the Company has recently started undertaking custom manufacturing services for complex or novel chemical compounds. The Company started commercial production of Pharma Intermediate and API in 2018. It work out manufacturing activities at Rajkot, Gujarat, which comprise of two separate manufacturing blocks for manufacturing of Pharmaceutical Intermediate and APIs respectively with an aggr ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 34.99 -0.32 (-0.91%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 496.65 +3.45 (+0.7%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,364.50 +65.5 (+1.04%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 647.50 -33.4 (-4.91%) |
| Abbott India Ltd Pharmaceuticals | ₹ 25,635.00 -510 (-1.95%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,378.90 +20.9 (+1.54%) |
FAQs on Anlon Healthcare Ltd
1. Can I buy Anlon Healthcare Ltd from PL Capital? ›
2. Does Anlon Healthcare Ltd pay dividends? ›
3. What is the current share price of Anlon Healthcare Ltd ? ›
4. What is the 52-week high and low of Anlon Healthcare Ltd ? ›
5. What is the market capitalisation of Anlon Healthcare Ltd? ›
6. What is the current P/E ratio of Anlon Healthcare Ltd? ›
7. What is the current P/B ratio of Anlon Healthcare Ltd? ›
8. What is the shareholding pattern of Anlon Healthcare Ltd? ›
9. What is the 1-year return of Anlon Healthcare Ltd? ›
Start SIP in Anlon Healthcare Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
